129 related articles for article (PubMed ID: 8195579)
1. Prediction of response to haloperidol in schizophrenia: neuroendocrine, neuromorphological and clinical variables.
Mauri MC; Vita A; Giobbio GM; Ferrara A; Dieci M; Bitetto A; Altamura AC
Int Clin Psychopharmacol; 1994; 9(1):3-7. PubMed ID: 8195579
[TBL] [Abstract][Full Text] [Related]
2. Dexamethasone suppression test in schizophrenia: relationship to symptomatology, ventricular enlargement, and outcome.
Tandon R; Mazzara C; DeQuardo J; Craig KA; Meador-Woodruff JH; Goldman R; Greden JF
Biol Psychiatry; 1991 May; 29(10):953-64. PubMed ID: 1676605
[TBL] [Abstract][Full Text] [Related]
3. Lateral ventricular enlargement and clinical response in schizophrenia.
Smith RC; Baumgartner R; Ravichandran GK; Mauldin M; Burd A; Vroulis G; Gordon J; Calderon M
Psychiatry Res; 1985 Mar; 14(3):241-53. PubMed ID: 3858896
[TBL] [Abstract][Full Text] [Related]
4. Ventricular enlargement, clinical correlates and treatment outcome in chronic schizophrenic inpatients.
Wilms G; Van Ongeval C; Baert AL; Claus A; Bollen J; De Cuyper H; Eneman M; Malfroid M; Peuskens J; Heylen S
Acta Psychiatr Scand; 1992 Apr; 85(4):306-12. PubMed ID: 1375802
[TBL] [Abstract][Full Text] [Related]
5. Depression dexamethasone nonsuppression and negative symptoms in schizophrenia.
Addington D; Addington J
Can J Psychiatry; 1990 Jun; 35(5):430-3. PubMed ID: 2372754
[TBL] [Abstract][Full Text] [Related]
6. Computerized brain tomography measures compared with spontaneous and suppressed plasma cortisol levels in major depression.
Schlegel S; von Bardeleben U; Wiedemann K; Frommberger U; Holsboer F
Psychoneuroendocrinology; 1989; 14(3):209-16. PubMed ID: 2756074
[TBL] [Abstract][Full Text] [Related]
7. Negative and depressive symptoms in suicidal schizophrenics.
Jones JS; Stein DJ; Stanley B; Guido JR; Winchel R; Stanley M
Acta Psychiatr Scand; 1994 Feb; 89(2):81-7. PubMed ID: 8178667
[TBL] [Abstract][Full Text] [Related]
8. Depression, negative and positive symptoms, and the DST in schizophrenia.
Minas IH; Jackson HJ; Joshua SD; Burgess PM
Schizophr Res; 1990; 3(5-6):321-7. PubMed ID: 2282337
[TBL] [Abstract][Full Text] [Related]
9. Negative symptoms of schizophrenia and the dexamethasone suppression test.
Garyfallos G; Lavrentiadis G; Amoutzias D; Monas K; Manos N
Acta Psychiatr Scand; 1993 Dec; 88(6):425-8. PubMed ID: 8310850
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting the clinical response to haloperidol therapy in schizophrenia.
Bareggi SR; Mauri M; Cavallaro R; Regazzetti MG; Moro AR
Clin Neuropharmacol; 1990; 13 Suppl 1():S29-34. PubMed ID: 2379182
[TBL] [Abstract][Full Text] [Related]
11. [Psychopathologic changes in chronic schizophrenic patients following withdrawal of neuroleptics: relation to therapeutic, neuroendocrine and computer tomography variables].
Albus M; Naber D; Ackenheil M; Bürke H; Müller-Spahn F; Münch U; Reinertshofer T; Schmidt-Vanderheyden W; Weber G; Wissmann J
Fortschr Neurol Psychiatr; 1986 Jan; 54(1):15-20. PubMed ID: 2868983
[TBL] [Abstract][Full Text] [Related]
12. Suspension therapy in acute schizophrenia. Clinical and neuroendocrine/biochemical effects of abrupt discontinuation of neuroleptic medication.
Kuhs H; Folkerts H
Neuropsychobiology; 1995; 31(3):135-45. PubMed ID: 7609862
[TBL] [Abstract][Full Text] [Related]
13. Depressive symptoms and schizophrenia a psychopharmacological approach.
Mauri MC; Bravin S; Fabiano L; Vanni S; Boscati L; Invernizzi G
Encephale; 1995; 21(5):555-8. PubMed ID: 8529564
[TBL] [Abstract][Full Text] [Related]
14. The BPRS in assessing symptom correlates of cerebral ventricular enlargement in acute and chronic schizophrenia.
Bishop RJ; Golden CJ; MacInnes WD; Chu CC; Ruedrich SL; Wilson J
Psychiatry Res; 1983 Jul; 9(3):225-31. PubMed ID: 6604928
[TBL] [Abstract][Full Text] [Related]
15. Subjective response to neuroleptics and outcome in schizophrenia: a re-examination comparing two measures.
Hogan TP; Awad AG
Psychol Med; 1992 May; 22(2):347-52. PubMed ID: 1615101
[TBL] [Abstract][Full Text] [Related]
16. Depressive signs and symptoms in schizophrenia: a prospective blinded trial of olanzapine and haloperidol.
Tollefson GD; Sanger TM; Lu Y; Thieme ME
Arch Gen Psychiatry; 1998 Mar; 55(3):250-8. PubMed ID: 9510219
[TBL] [Abstract][Full Text] [Related]
17. Clinical correlates of body weight changes in schizophrenia.
Lawson WB; Karson CN
J Neuropsychiatry Clin Neurosci; 1994; 6(2):187-8. PubMed ID: 8044044
[TBL] [Abstract][Full Text] [Related]
18. Seasonal variation in the dexamethasone suppression test: a longitudinal study in chronic schizophrenics and in healthy subjects.
Monteleone P; Piccolo A; Martino M; Maj M
Neuropsychobiology; 1994; 30(2-3):61-5. PubMed ID: 7800165
[TBL] [Abstract][Full Text] [Related]
19. Dexamethasone suppression test and depressive symptoms in schizophrenics and endogenous depressed patients.
Perényi A; Frecska E; Rihmer Z; Arató M
Pharmacopsychiatry; 1987 Mar; 20(2):48-50. PubMed ID: 3588661
[TBL] [Abstract][Full Text] [Related]
20. Positive versus negative symptoms in schizophrenia: response to haloperidol.
Palao DJ; Arauxo A; Brunet M; Marquez M; Bernardo M; Ferrer J; Gonzalez-Monclus E
Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jan; 18(1):155-64. PubMed ID: 8115670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
